Immatics NV (IMTX)
7.59
-0.85
(-10.07%)
USD |
NASDAQ |
Oct 02, 16:00
7.60
+0.01
(+0.13%)
After-Hours: 20:00
Immatics Profit Margin (Quarterly) : -683.4% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -683.4% |
| March 31, 2026 | -759.5% |
| December 31, 2025 | -180.6% |
| September 30, 2025 | -974.4% |
| June 30, 2025 | -1.49K% |
| March 31, 2025 | -214.5% |
| December 31, 2024 | 79.75% |
| September 30, 2024 | -10.49% |
| June 30, 2024 | -95.93% |
| March 31, 2024 | -7.40% |
| December 31, 2023 | -164.2% |
| September 30, 2023 | -447.0% |
| June 30, 2023 | -110.1% |
| March 31, 2023 | -201.6% |
| December 31, 2022 |
| Date | Value |
|---|---|
| September 30, 2022 | |
| June 30, 2022 | -81.21% |
| March 31, 2022 | 83.24% |
| December 31, 2021 | -106.7% |
| September 30, 2021 | -422.2% |
| June 30, 2021 | -511.4% |
| March 31, 2021 | -308.2% |
| December 31, 2020 | -50.95% |
| September 30, 2020 | -2.08K% |
| June 30, 2020 | -309.3% |
| March 31, 2020 | -121.9% |
| December 31, 2019 | -340.7% |
| September 30, 2019 | -98.36% |
| June 30, 2019 | -124.4% |
| March 31, 2019 | -162.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| MediGene AG | -- |
| InflaRx NV | -- |
| BioNTech SE | -777.3% |
| Twist Bioscience Corp. | -29.61% |
| Prime Medicine, Inc. | -3.65K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -46.59% |
| Return on Assets | -38.65% |
| Return on Invested Capital | -44.99% |
| Operating Margin (Quarterly) | -735.0% |
| Return on Net Operating Assets | -283.2% |